3D Systems Announces $31 Million Equitization Transaction

3D Systems Announces $31 Million Equitization Transaction GlobeNewswire December 09, 2025 ROCK HILL, S.C., Dec. 09, 2025 (GLOBE NEWSWIRE) — 3D Systems Corporation (NYSE: DDD) today announced that it has entered into separate, privately negotiated agreements with a limited number of holders (the “Transaction Participants”) of its existing 0% Convertible Senior Notes due 2026 (the […]

Carta Healthcare Wins ‘Best Use of AI in Healthcare’ in 2025 Merit Awards for Technology

Win is second in a row for industry-leading clinical data abstraction provider Carta Healthcare®, a leading provider of AI-powered clinical data abstraction solutions, announced today that it has earned first-place Gold recognition for “Best Use of AI in Healthcare” in the 2025 Merit Awards for Technology. The company also won the award last year. https://mma.prnewswire.com/media/2480470/Carta_Healthcare__Logo.jpg

Brook.ai Wins Top Digital Health Award for Pioneering Work in AI-Powered Remote Care Management

Healthcare Technology Leader Recognized for Second Consecutive Year for Innovative Approach to Chronic Disease Management Brook.ai, the company making remote care an integral part of U.S. healthcare by extending continuity of care outside the traditional practice setting, today announced its recognition with a Gold Award for Remote Patient Monitoring in the Connected Digital Health category

Cetera’s Tax-Focused Community, Avantax, Welcomes Prestige Global Private Wealth

Seasoned financial advisor Waheed Siddiqui moves from Citigroup Global Markets Inc., seeking the independence and resources to enhance the client experience and offer tax-intelligent advice Cetera welcomes financial advisor Waheed Siddiqui and his firm, Prestige Global Private Wealth, to Avantax, a community of tax-focused financial professionals within Cetera. Driven by a desire to embrace his

Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025

100% of patients in Cohorts 1-3 remain free of cytokine release syndrome CRIS-7-derived CD3 design underpins a controlled T-cell response, supporting the differentiated safety profile, combinability with standard of care SEATTLE, WA / ACCESS Newswire / December 9, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based

Blue Gold Announces Successful Smart Contract Audit by Nethermind, Strengthening Security and Transparency Ahead of Standard Gold Coin Launch on Base

Blue Gold Announces Successful Smart Contract Audit by Nethermind, Strengthening Security and Transparency Ahead of Standard Gold Coin Launch on Base GlobeNewswire December 09, 2025 NEW YORK, NY, Dec. 09, 2025 (GLOBE NEWSWIRE) — Blue Gold Limited (Nasdaq: BGL) (“Blue Gold” or the “Company”), a next-generation gold development and technology company, today announced the successful

EPSMomentum Introduces AI Analyst to Transform Stock Analysis for Investors

EPSMomentum Introduces AI Analyst to Transform Stock Analysis for Investors Combining AI-driven analysis with original source documents, EPSMomentum provides investors with clear, actionable stock insight. GlobeNewswire December 09, 2025 New York, NY, Dec. 09, 2025 (GLOBE NEWSWIRE) — EPSMomentum, a NYC-based provider of data-driven analytics and unique datasets for smarter investing, today announced the launch

Inspira Technologies Granted Patent in Japan for the INSPIRA(TM) ART System’s Convertible Dual Lumen Cannula Device and Method of Use

Inspira Technologies Granted Patent in Japan for the INSPIRA(TM) ART System's Convertible Dual Lumen Cannula Device and Method of Use GlobeNewswire December 09, 2025 RA'ANANA, Israel, Dec. 09, 2025 (GLOBE NEWSWIRE) — Inspira(TM) Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira,” “Inspira Technologies,” or the “Company“), a pioneer in innovative life-support and diagnostic technologies, announced today

Sesen Launches TrialS, a Next Generation Platform for Regulatory, Clinical, and Labeling Translation Validation

BOSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) — Sesen today announced the launch of TrialS, a next generation regulatory translation validation platform designed to help life sciences organizations achieve greater accuracy, consistency, and regulatory alignment across global clinical and labeling submissions. TrialS introduces a modern approach to regulatory translation by addressing one of the most persistent

CTERA Ransom Protect Achieves 100% Detection Across Leading Ransomware Families, Stopping Attacks in Seconds

New York, NY, Dec. 09, 2025 (GLOBE NEWSWIRE) — CTERA, a leader in intelligent data management, today announced the results of an independent evaluation of its Ransom Protect feature available as part of its CTERA Cyber Protection Data Service, demonstrating rapid ransomware detection, prevention, and protection capabilities across eight major ransomware families, including advanced strains

Scroll to Top